Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

NCT05142774 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
728
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Organon and Co